These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9322474)

  • 1. Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management.
    Horlocker TT; Heit JA
    Anesth Analg; 1997 Oct; 85(4):874-85. PubMed ID: 9322474
    [No Abstract]   [Full Text] [Related]  

  • 2. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
    Bergqvist D
    Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-molecular-weight heparin: biochemistry, pharmacology, and concurrent drug precautions.
    Heit JA
    Reg Anesth Pain Med; 1998; 23(6 Suppl 2):135-9. PubMed ID: 9845385
    [No Abstract]   [Full Text] [Related]  

  • 4. Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
    Hirsh J; Levine MN
    Eur J Surg Suppl; 1994; (571):9-22. PubMed ID: 7519092
    [No Abstract]   [Full Text] [Related]  

  • 5. Hirudin and thrombosis prophylaxis.
    Turpie AG
    Lancet; 1996 Mar; 347(9002):632-3. PubMed ID: 8596373
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-discharge deep-vein thrombosis after orthopaedic surgery.
    Simini B
    Lancet; 1996 Oct; 348(9035):1179; author reply 1179-80. PubMed ID: 8888207
    [No Abstract]   [Full Text] [Related]  

  • 7. Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients.
    Kakkar VV
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):9-19. PubMed ID: 9399405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of postoperative deep vein thrombosis of the lower limbs].
    Baeshko AA; Sysov AV; Rolevich AI
    Klin Khir; 1998; (2):38-41. PubMed ID: 9615084
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylaxis of venous thromboembolism in surgery.
    Verhaeghe R; Verstraete M
    Acta Chir Belg; 1997 Jun; 97(3):106-9. PubMed ID: 9224512
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-benefit analysis of prophylaxis against deep vein thrombosis in surgery.
    Hauch O; Khattar SC; Jørgensen LN
    Semin Thromb Hemost; 1991; 17 Suppl 3():280-3. PubMed ID: 1661436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and therapy of postoperative thrombosis and embolism.
    Röggla M; Wagner A; Malzer R; Gamper G; Janata K; Röggla G
    Acta Anaesthesiol Scand Suppl; 1997; 111():217-9. PubMed ID: 9421020
    [No Abstract]   [Full Text] [Related]  

  • 12. Deep venous thrombosis: low-molecular-weight heparins in perioperative prophylaxis.
    Merli G
    Cleve Clin J Med; 1995; 62(6):368-9. PubMed ID: 8556807
    [No Abstract]   [Full Text] [Related]  

  • 13. Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery: current status and perspectives.
    Breyer HG
    Semin Thromb Hemost; 1991 Oct; 17(4):336-42. PubMed ID: 1666453
    [No Abstract]   [Full Text] [Related]  

  • 14. Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomised clinical trials.
    Palmer AJ; Schramm W; Kirchhof B; Bergemann R
    Haemostasis; 1997; 27(2):65-74. PubMed ID: 9212354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
    Bergqvist D
    Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463
    [No Abstract]   [Full Text] [Related]  

  • 16. Applying the ASRA guidelines to the use of low-molecular-weight heparin thromboprophylaxis in major orthopedic surgery.
    O'Rourke MR; Rosenquist RW
    J Arthroplasty; 2004 Oct; 19(7):919-22. PubMed ID: 15483810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the prevention of venous thromboembolic disease in orthopaedics: the introduction of LMWH.
    Colwell CW; Paiement G; Pellegrini VD; Salvati EA; Stulberg BN
    Contemp Orthop; 1993 Dec; 27(6):551-77. PubMed ID: 10146586
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in prophylaxis against deep vein thrombosis.
    Wheatley T; Veitch PS
    Br J Anaesth; 1997 Feb; 78(2):118-20. PubMed ID: 9068323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparin(s).
    Barrowcliffe TW
    Br J Haematol; 1995 May; 90(1):1-7. PubMed ID: 7786769
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
    Eriksson BI; Kälebo P; Risberg B
    Semin Thromb Hemost; 1993; 19 Suppl 1():122-7. PubMed ID: 8395714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.